Farther Finance Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
HWAM
WCM
CNAM
ETC
YIH
SOADOR
LSERS
Farther Finance Advisors's SUPN Position: Q2 2026 in Review
Farther Finance Advisors reduced its Supernus Pharmaceuticals (SUPN) stake by 19% in Q2 2026, selling an estimated $2.59K and leaving 229 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4380.
Farther Finance Advisors first reported a position in SUPN in Q4 2022 and has held it in 15 quarters since. The position peaked at $15.9K in Q4 2025. 50 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Farther Finance Advisors held 229 shares of Supernus Pharmaceuticals worth $10.7K as of Q2 2026.
- Farther Finance Advisors sold 54 Supernus Pharmaceuticals shares in Q2 2026, an estimated $2.59K.
- Supernus Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4380 holding.
- Farther Finance Advisors first reported a position in Supernus Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- Farther Finance Advisors's Supernus Pharmaceuticals position peaked at $15.9K in Q4 2025.
- 50 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.